National Health Investors, Inc. (NYSE:NHI) Given Consensus Recommendation of "Buy" by Brokerages

Key Points

• National Health Investors, Inc. (NYSE:NHI) has received an average recommendation of "Buy" from five brokerages, with a 1-year price target set at $84.20.
• The company recently declared a quarterly dividend of $0.92 per share, reflecting an increase from the previous dividend of $0.90, indicating a strong commitment to returning value to shareholders.
• National Health Investors reported a 6.7% year-over-year revenue increase, posting $70.27 million for the quarter, alongside an EPS of $1.22 which exceeded analysts' expectations.

Shares of National Health Investors, Inc. (NYSE:NHI - Get Free Report) have received an average recommendation of "Buy" from the five brokerages that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold recommendation, three have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $84.20.

Several analysts recently commented on the stock. Truist Financial increased their price objective on shares of National Health Investors from $77.00 to $81.00 and gave the company a "buy" rating in a research report on Friday, August 15th. KeyCorp raised shares of National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 price target on the stock in a report on Thursday, July 10th. Wedbush raised shares of National Health Investors to a "strong-buy" rating in a report on Wednesday, July 2nd. Finally, Wells Fargo & Company raised their price target on shares of National Health Investors from $76.00 to $80.00 and gave the company an "equal weight" rating in a report on Wednesday, August 27th.

Institutional Trading of National Health Investors

A number of institutional investors have recently made changes to their positions in NHI. Smartleaf Asset Management LLC grew its holdings in shares of National Health Investors by 49.8% in the first quarter. Smartleaf Asset Management LLC now owns 442 shares of the real estate investment trust's stock valued at $33,000 after purchasing an additional 147 shares in the last quarter. Assetmark Inc. grew its holdings in shares of National Health Investors by 19.0% in the second quarter. Assetmark Inc. now owns 925 shares of the real estate investment trust's stock valued at $65,000 after purchasing an additional 148 shares in the last quarter. M&T Bank Corp grew its holdings in shares of National Health Investors by 4.4% in the first quarter. M&T Bank Corp now owns 3,969 shares of the real estate investment trust's stock valued at $293,000 after purchasing an additional 168 shares in the last quarter. Creative Planning grew its holdings in shares of National Health Investors by 2.2% in the second quarter. Creative Planning now owns 8,217 shares of the real estate investment trust's stock valued at $576,000 after purchasing an additional 177 shares in the last quarter. Finally, Aviance Capital Partners LLC grew its holdings in shares of National Health Investors by 3.8% in the second quarter. Aviance Capital Partners LLC now owns 5,225 shares of the real estate investment trust's stock valued at $366,000 after purchasing an additional 189 shares in the last quarter. Hedge funds and other institutional investors own 62.51% of the company's stock.

National Health Investors Stock Performance

Shares of NHI stock opened at $78.13 on Tuesday. National Health Investors has a one year low of $65.13 and a one year high of $85.69. The company's 50-day moving average is $75.06 and its 200 day moving average is $73.77. The company has a market capitalization of $3.71 billion, a price-to-earnings ratio of 24.96, a price-to-earnings-growth ratio of 3.37 and a beta of 0.76. The company has a debt-to-equity ratio of 0.75, a quick ratio of 10.91 and a current ratio of 10.91.

National Health Investors (NYSE:NHI - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The real estate investment trust reported $1.22 EPS for the quarter, beating the consensus estimate of $1.16 by $0.06. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. The company had revenue of $70.27 million for the quarter, compared to the consensus estimate of $86.46 million. During the same period in the prior year, the firm posted $1.18 EPS. National Health Investors's revenue for the quarter was up 6.7% on a year-over-year basis. Sell-side analysts expect that National Health Investors will post 4.41 EPS for the current fiscal year.

National Health Investors Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be issued a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.7%. The ex-dividend date of this dividend is Tuesday, September 30th. This is a boost from National Health Investors's previous quarterly dividend of $0.90. National Health Investors's payout ratio is 115.02%.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.